Man is the new mouse: Elective surgery as a key translational model for multi-organ dysfunction and sepsis

Journal of the Intensive Care Society

Volumn 16, Issue 2, 2015, Pages 154-163

  Cain, David J ^a   Del Arroyo, Ana Gutierrez ^a   Ackland, Gareth L ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Animal model; Human; Research; Sepsis; Surgery

Indexed keywords

ARTICLE; ARTIFICIAL VENTILATION; COMORBIDITY; CRITICALLY ILL PATIENT; DISEASE ASSOCIATION; ELECTIVE SURGERY; HUMAN; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; MULTIPLE ORGAN FAILURE; PHENOTYPE; SEPSIS;

EID: 84945198877     PISSN: 17511437     EISSN: None     Source Type: Journal    
DOI: 10.1177/1751143714564826     Document Type: Article

References (111)

1. Marco Ranieri V, Thompson BT, Philip S Barie, et al. Drotrecogin Alfa (Activated) in adults with septic shock. N Engl J Med 2012; 366: 2055–2064.
2. Sprung CL, Annane D, Keh D, et al. Hydrocortisone therapy for patients with septic shock. N Engl J Med 2008; 358: 111–124.
3. Alejandria MM, Lansang MA, Dans LF, et al. 3rd. Intravenous immunoglobulin for treating sepsis, severe sepsis and septic shock. Cochrane Database Syst Rev 2013; 9: CD001090.
4. Angus DC, Birmingham MC, Balk RA, et al. E5 murine monoclonal antiendotoxin antibody in gramnegative sepsis: a randomized controlled trial. JAMA 2000; 283: 1723–1730.
5. Rimmer E, Kumar A, Doucette S, et al. Activated protein C and septic shock: a propensity-matched cohort study. Crit Care Med 2012; 40: 2974–2981.
6. Montecino-Rodriguez E, Berent-Maoz B, and Dorshkind K. Causes, consequences, and reversal of immune system aging. J Clin Invest 2013; 123: 958–965.
7. Frink M, Pape HC, van Griensven M, et al. Influence of sex and age on mods and cytokines after multiple injuries. Shock 2007; 27: 151–156.
8. Sakr Y, Elia C, Mascia L, et al. The influence of gender on the epidemiology of and outcome from severe sepsis. Crit Care 2013; 17: R50.
9. Mayr FB, Yende S, Linde-Zwirble WT, et al. Infection rate and acute organ dysfunction risk as explanations for racial differences in severe sepsis. JAMA 2010; 303: 2495–2503.
10. Fildes JE, Shaw SM, Yonan N, et al. The immune system and chronic heart failure: is the heart in control? J Am Coll Cardiol 2009; 53: 1013–1020.
11. Schreiber RD, Old LJ, and Smyth MJ. Cancer immunoediting: integrating immunity’s roles in cancer suppression and promotion. Science 2011; 331: 1565–1570.
12. Kanoh S, and Rubin BK. Mechanisms of action and clinical application of macrolides as immunomodulatory medications. Clin Microbiol Rev 2010; 23: 590–615.
13. Kalghatgi S, Spina CS, Costello JC, et al. Bactericidal antibiotics induce mitochondrial dysfunction and oxidative damage in mammalian cells. Sci Transl Med 2013; 5: 192ra85.
14. Mikawa K, Akamatsu H, Nishina K, et al. Propofol inhibits human neutrophil functions. Anesth Analg 1998; 87: 695–700.
15. Clarke AR, Purdie CA, Harrison DJ, et al. Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 1993; 362: 849–852.
16. Dellinger RP, Levy MM, Rhodes A, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med 2013; 39: 165–228.
17. Cain D, Gutierrez del Arroyo A, and Ackland G. Uncontrolled sepsis: a systematic review of translational immunology studies in intensive care medicine. Intensive Care Med Experimental 2013; 2: 1–25.
18. Chang SS, Hsieh WH, Liu TS, et al. Multiplex PCR system for rapid detection of pathogens in patients with presumed sepsis-a systemic review and meta-analysis. PLos One 2013; 8: e62323.
19. Menu P, and Vince JE. The NLRP3 inflammasome in health and disease: the good, the bad and the ugly. Clin Exp Immunol 2011; 166: 1–15.
20. Vandenesch F, Lina G, and Henry T. Staphylococcus aureus hemolysins, bi-component leukocidins, and cytolytic peptides: a redundant arsenal of membranedamaging virulence factors? Front Cell Infect Microbiol 2012; 2: 12.
21. Adib-Conquy M, and Cavaillon J-M. Compensated anti-inflammatory response syndrome. Thromb Haemost 2009; 101: 36–47.
22. Seok J, Warren HS, Cuenca AG, et al. Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc Natl Acad Sci USA 2013; 110: 3507–3512.
23. Xiao W, Mindrinos MN, Seok J, et al. A genomic storm in critically injured humans. J Exp Med 2011; 208: 2581–2590.
24. De Maio A, Torres MB, and Reeves RH. Genetic determinants influencing the response to injury, inflammation, and sepsis. Shock 2005; 23: 11–17.
25. Stewart D, Fulton WB, Wilson C, et al. Genetic contribution to the septic response in a mouse model. Shock 2002; 18: 342–347.
26. Radermacher P, and Haouzi P. A mouse is not a rat is not a man: species-specific metabolic responses to sepsis–a nail in the coffin of murine models for critical care research? Intensive Care Med Experimental 2013; 1: 7.
27. Doevendans PA, Daemen MJ, de Muinck ED, et al. Cardiovascular phenotyping in mice. Cardiovasc Res 1998; 39: 34–49.
28. Salzman NH, de Jong H, Paterson Y, et al. Analysis of 16S libraries of mouse gastrointestinal microflora reveals a large new group of mouse intestinal bacteria. Microbiology 2002; 148: 3651–3660.
29. Rehli M. Of mice and men: species variations of Tolllike receptor expression. Trends Immunol 2002; 23: 375–378.
30. Lund J, Sato A, Akira S, et al. Toll-like receptor 9-mediated recognition of Herpes simplex virus-2 by plasmacytoid dendritic cells. J Exp Med 2003; 198: 513–520.
31. Risso A. Leukocyte antimicrobial peptides: multifunctional effect or molecules of innate immunity. J Leukoc Biol 2000; 68: 785–792.
32. Warren HS. Editorial: mouse models to study sepsis syndrome in humans. J Leukoc Biol 2009; 86: 199–201.
33. Doeing DC, Borowicz JL, and Crockett ET. Gender dimorphism in differential peripheral blood leukocyte counts in mice using cardiac, tail, foot, and saphenous vein puncture methods. BMC Clin Pathol 2003; 3: 3.
34. Macchiarini F, Manz MG, Palucka AK, et al. Humanized mice: are we there yet? J Exp Med 2005; 202: 1307–1311.
35. Shultz LD, Ishikawa F, and Greiner DL. Humanized mice in translational biomedical research. Nat Rev Immunol 2007; 7: 118–130.
36. Martin GS, Mannino DM, Eaton S, et al. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003; 348: 1546–1554.
37. Singer M, De Santis V, Vitale D, et al. Multiorgan failure is an adaptive, endocrine-mediated, metabolic response to overwhelming systemic inflammation. Lancet 2004; 364: 545–548.
38. Singer M, and Glynne P. Treating critical illness: the importance of first doing no harm. PLoS Med 2005; 2: e167.
39. Andreasen AS, Krabbe KS, Krogh-Madsen R, et al. Human endotoxemia as a model of systemic inflammation. Curr Med Chem 2008; 15: 1697–1705.
40. Krabbe KS, Bruunsgaard H, Hansen CM, et al. Ageing is associated with a prolonged fever response in human endotoxemia. Clin Diagn Lab Immunol 2001; 8: 333–338.
41. Damas P, Ledoux D, Nys M, et al. Cytokine serum level during severe sepsis in human IL-6 as a marker of severity. Ann Surg 1992; 215: 356–362.
42. Futier E, Constantin JM, Paugam-Burtz C, et al. A trial of intraoperative low-tidal-volume ventilation in abdominal surgery. N Engl J Med 2013; 369: 428–437.
43. Brower RG, and Fessler HE. Mechanical ventilation in acute lung injury and acute respiratory distress syndrome. Clin Chest Med 2000; 21: 491–510, viii.
44. Wang HE, Shapiro NI, Griffin R, et al. Chronic medical conditions and risk of sepsis. PLoS One 2012; 7: e48307.
45. Weiser TG, Regenbogen SE, Thompson KD, et al. An estimation of the global volume of surgery: a modelling strategy based on available data. Lancet 2008; 372: 139–144.
46. Pearse RM, Harrison DA, James P, et al. Identification and characterisation of the high-risk surgical population in the United Kingdom. Crit Care 2006; 10: R81.
47. Greif R, Akca O, Horn EP, et al. Supplemental perioperative oxygen to reduce the incidence of surgicalwound infection. N Engl J Med 2000; 342: 161–167.
48. Belda FJ, Aguilera L, Garcia de la Asuncion J, et al. Supplemental perioperative oxygen and the risk of surgical wound infection: a randomized controlled trial. JAMA 2005; 294: 2035–2042.
49. Melling AC, Ali B, Scott EM, et al. Effects of preoperative warming on the incidence of wound infection after clean surgery: a randomised controlled trial. Lancet 2001; 358: 876–880.
50. Charlson M, Szatrowski TP, Peterson J, et al. Validation of a combined comorbidity index. J Clin Epidemiol 1994; 47: 1245–1251.
51. Warnold I, and Lundholm K. Clinical significance of preoperative nutritional status in 215 noncancer patients. Ann Surg 1984; 199: 299–305.
52. Windsor JA, and Hill GL. Weight loss with physiologic impairment. A basic indicator of surgical risk. Ann Surg 1988; 207: 290–296.
53. Copeland GP, Jones D, and Walters M. POSSUM: a scoring system for surgical audit. Br J Surg 1991; 78: 355–360.
54. Manilich E, Vogel JD, Kiran RP, et al. Key factors associated with postoperative complications in patients undergoing colorectal surgery. Dis Colon Rectum 2013; 56: 64–71.
55. Gupta H, Gupta PK, Schuller D, et al. Development and validation of a risk calculator for predicting postoperative pneumonia. Mayo Clinic Proc 2013; 88: 1241–1249.
56. Bateman BT, Schmidt U, Berman MF, et al. Temporal trends in the epidemiology of severe postoperative sepsis after elective surgery: a large, nationwide sample. Anesthesiology 2010; 112: 917–925.
57. Lee TH, Marcantonio ER, Mangione CM, et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation 1999; 100: 1043–1049.
58. Angus DC, Linde-Zwirble WT, Lidicker J, et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001; 29: 1303–1310.
59. Morris AH. Treatment algorithms and protocolized care. Curr Opin Crit Care 2003; 9: 236–240.
60. Stringer WW. Cardiopulmonary exercise testing: current applications. Expert Rev Resp Med 2010; 4: 179–188.
61. White M, Mahon V, Grealy R, et al. Post-operative infection and sepsis in humans is associated with deficient gene expression of gammac cytokines and their apoptosis mediators. Crit Care 2011; 15: R158.
62. Henriksen MG, Hessov I, Dela F, et al. Effects of preoperative oral carbohydrates and peptides on postoperative endocrine response, mobilization, nutrition and muscle function in abdominal surgery. Acta Anaesthesiol Scand 2003; 47: 191–199.
63. Kobayashi M, Mohri Y, Inoue Y, et al. Continuous follow-up of surgical site infections for 30 days after colorectal surgery. World J Surg 2008; 32: 1142–1146.
64. Brealey D, Brand M, Hargreaves I, et al. Association between mitochondrial dysfunction and severity and outcome of septic shock. Lancet 2002; 360: 219–223.
65. Moore FA, Moore EE, Poggetti R, et al. Gut bacterial translocation via the portal vein: a clinical perspective with major torso trauma. J Trauma 1991; 31: 629–636.
66. Izquierdo M, Ruiz-Granell R, Bonanad C, et al. Value of early cardiovascular magnetic resonance for the prediction of adverse arrhythmic cardiac events after a first noncomplicated ST-segment-elevation myocardial infarction. Circ Cardiovasc Imaging 2013; 6: 755–761.
67. Purdon PL, Pierce ET, Bonmassar G, et al. Simultaneous electroencephalography and functional magnetic resonance imaging of general anesthesia. Ann New York Acad Sci 2009; 1157: 61–70.
68. Zhang Q, Raoof M, Chen Y, et al. Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature 2010; 464: 104–107.
69. Simmons JD, Lee YL, Mulekar S, et al. Elevated levels of plasma mitochondrial DNA DAMPs are linked to clinical outcome in severely injured human subjects. Ann Surg 2013; 258: 591–596.
70. Bianchetti R, Lucchini G, Crosti P, et al. Dependence of mitochondrial protein synthesis initiation on formylation of the initiator methionyl-tRNAf. J Biol Chem 1977; 252: 2519–2523.
71. Taanman JW. The mitochondrial genome: structure, transcription, translation and replication. Biochim Biophys Acta 1999; 1410: 103–123.
72. Wrigge H, Zinserling J, Stuber F, et al. Effects of mechanical ventilation on release of cytokines into systemic circulation in patients with normal pulmonary function. Anesthesiology 2000; 93: 1413–1417.
73. Perkins GD, Gates S, Park D, et al. The beta agonist lung injury trial prevention. A randomized controlled trial. Am J Respir Crit Care Med 2014; 189: 674–683.
74. Shyamsundar M, McAuley DF, Shields MO, et al. Effect of simvastatin on physiological and biological outcomes in patients undergoing esophagectomy: a randomized placebo-controlled trial. Ann Surg 2014; 259: 26–31.
75. McAuley DF, Laffey JG, O’Kane CM, et al. Simvastatin in the acute respiratory distress syndrome. N Engl J Med 2014; 371: 1695–1703.
76. Koike K, Moore FA, Moore EE, et al. Endotoxin after gut ischemia/reperfusion causes irreversible lung injury. J Surg Res 1992; 52: 656–662.
77. Condliffe AM, Kitchen E, and Chilvers ER. Neutrophil priming: pathophysiological consequences and underlying mechanisms. Clin Sci 1998; 94: 461–471.
78. Moore EE, Moore FA, Harken AH, et al. The twoevent construct of postinjury multiple organ failure. Shock 2005; 24 Suppl 1: 71–74.
79. Barsness KA, Arcaroli J, Harken AH, et al. Hemorrhage-induced acute lung injury is TLR-4 dependent. Am J Physiol Regul Integr Comp Physiol 2004; 287: R592–R599.
80. Ayala A, Chung CS, Lomas JL, et al. Shock-induced neutrophil mediated priming for acute lung injury in mice: divergent effects of TLR-4 and TLR-4/FasL deficiency. Am J Pathol 2002; 161: 2283–2294.
81. Xiang M, Shi X, Li Y, et al. Hemorrhagic shock activation of NLRP3 inflammasome in lung endothelial cells. J Immunol 2011; 187: 4809–4817.
82. Buttenschoen K, Schneider ME, Utz K, et al. Effect of major abdominal surgery on endotoxin release and expression of Toll-like receptors 2/4. Langenbecks Arch Surg 2009; 394: 293–302.
83. Limaye AP, Kirby KA, Rubenfeld GD, et al. Cytomegalovirus reactivation in critically ill immunocompetent patients. JAMA 2008; 300: 413–422.
84. Luyt CE, Combes A, Deback C, et al. Herpes simplex virus lung infection in patients undergoing prolonged mechanical ventilation. Am J Respir Crit Care Med 2007; 175: 935–942.
85. Guan J, Liu S, Lin Z, et al. Severe sepsis facilitates intestinal colonization by ESBL-producing klebsiella pneumoniae and transfer of the SHV-18 resistance gene to escherichia coli during antimicrobial treatment. Antimicrob Agents Chemother 2014; 58: 1039–1046.
86. Hotchkiss RS, Tinsley KW, Swanson PE, et al. Sepsisinduced apoptosis causes progressive profound depletion of B and CD4� T lymphocytes in humans. J Immunol 2001; 166: 6952–6963.
87. Ni Choileain N, MacConmara M, Zang Y, et al. Enhanced regulatory T cell activity is an element of the host response to injury. J Immunol 2006; 176: 225–236.
88. Delano MJ, Scumpia PO, Weinstein JS, et al. MyD88-dependent expansion of an immature GR-1(�)CD11b(�) population induces T cell suppression and Th2 polarization in sepsis. J Exp Med 2007; 204: 1463–1474.
89. Bhatti I, Peacock O, Lloyd G, et al. Preoperative hematologic markers as independent predictors of prognosis in resected pancreatic ductal adenocarcinoma: neutrophil-lymphocyte versus platelet-lymphocyte ratio. Am J Surg 2010; 200: 197–203.
90. Garcea G, Ladwa N, Neal CP, et al. Preoperative neutrophil-to-lymphocyte ratio (NLR) is associated with reduced disease-free survival following curative resection of pancreatic adenocarcinoma. World J Surgery 2011; 35: 868–872.
91. Bhutta H, Agha R, Wong J, et al. Neutrophil-lymphocyte ratio predicts medium-term survival following elective major vascular surgery: a cross-sectional study. Vasc Endovasc Surg 2011; 45: 227–231.
92. Gibson PH, Croal BL, Cuthbertson BH, et al. Preoperative neutrophil-lymphocyte ratio and outcome from coronary artery bypass grafting. Am Heart J 2007; 154: 995–1002.
93. MacLean LD, Meakins JL, Taguchi K, et al. Host resistance in sepsis and trauma. Ann Surg 1975; 182: 207–217.
94. Savage DC. Microbial ecology of the gastrointestinal tract. Ann Rev Microbiol 1977; 31: 107–133.
95. Morowitz MJ, Babrowski T, Carlisle EM, et al. The human microbiome and surgical disease. Ann Surg 2011; 253: 1094–1101.
96. Ackland G, Grocott MP, and Mythen MG. Understanding gastrointestinal perfusion in critical care: so near, and yet so far. Crit Care 2000; 4: 269–281.
97. Alverdy J, Holbrook C, Rocha F, et al. Gut-derived sepsis occurs when the right pathogen with the right virulence genes meets the right host: evidence for in vivo virulence expression in Pseudomonas aeruginosa. Ann Surg 2000; 232: 480–489.
98. Marshall JC, Foster D, Vincent JL, et al. Diagnostic and prognostic implications of endotoxemia in critical illness: results of the MEDIC study. J Infect Dis 2004; 190: 527–534.
99. Roumen RM, Frieling JT, van Tits HW, et al. Endotoxemia after major vascular operations. J Vasc Surg 1993; 18: 853–857.
100. Rothenburger M, Soeparwata R, Deng MC, et al. The impact of anti-endotoxin core antibodies on endotoxin and cytokine release and ventilation time after cardiac surgery. J Am Coll Cardiol 2001; 38: 124–130.
101. Bennett-Guerrero E, Panah MH, Barclay GR, et al. Decreased endotoxin immunity is associated with greater mortality and/or prolonged hospitalization after surgery. Anesthesiology 2001; 94: 992–998.
102. Cruz DN, Antonelli M, Fumagalli R, et al. Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial. JAMA 2009; 301: 2445–2452.
103. Raghunathan K, Shaw A, Nathanson B, et al. Association between the choice of IV crystalloid and in-hospital mortality among critically ill adults with sepsis. Crit Care Med 2014; 42: 1585–1591.
104. Pro CESS Investigators Yealy DM, Kellum JA, et al. A randomized trial of protocol-based care for early septic shock. N Engl J Med 2014; 370: 1683–1693.
105. Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM consensus conference committee. American college of chest physicians/society of critical care medicine. Chest 1992; 101: 1644–1655.
106. Caironi P, Tognoni G, Masson S, et al. Albumin replacement in patients with severe sepsis or septic shock. N Engl J Med 2014; 370: 1412–1421.
107. Asfar P, Meziani F, Hamel JF, et al. High versus low blood-pressure target in patients with septic shock. N Engl J Med 2014; 370: 1583–1593.
108. Gordon AC, Mason AJ, Perkins GD, et al. The interaction of vasopressin and corticosteroids in septic shock: a pilot randomized controlled trial. Crit Care Med 2014; 42: 1325–1333.
109. Bernard GR, Francois B, Mira JP, et al. Evaluating the efficacy and safety of two doses of the polyclonal antitumor necrosis factor-alpha fragment antibody AZD9773 in adult patients with severe sepsis and/or septic shock: randomized, double-blind, placebo-controlled phase IIb study. Crit Care Med 2014; 42: 504–511.
110. Morelli A, Ertmer C, Westphal M, et al. Effect of heart rate control with esmolol on hemodynamic and clinical outcomes in patients with septic shock: a randomized clinical trial. JAMA 2013; 310: 1683–1691.
111. Mollen KP, Anand RJ, Tsung A, et al. Emerging paradigm: toll-like receptor 4-sentinel for the detection of tissue damage. Shock 2006; 26: 430–437.